Corneal Neovascularization

Image and content excerpted from the VisualDx clinical decision support system.


Image of Corneal Neovascularization

VisualDx images show variation in age, skin color, and disease stage. VisualDx has 10 images of Corneal Neovascularization.

Full text and additional images for Corneal Neovascularization are available in the following VisualDx packages:

Complete

See descriptions of all packages available or sign up for a Free 30-Day Trial of the Essentials Package.


ICD Codes

ICD-9-CM:
370.60 – Corneal neovascularization unspecified

ICD-10-CM:
H16.409 – Unspecified corneal neovascularization, unspecified eye

Synopsis

Neovascularization of the cornea, also called corneal pannus, is the growth of blood vessels from the limbus into the cornea. The blood vessels can be very superficial or deep in the corneal stroma. Corneal pannus is often divided into 2 classes: micropannus, which denotes vascular ingrowth of 2 mm or less and macropannus, which is ingrowth of greater than 2 mm. Neovascularization of the cornea is a nonspecific sign of ocular inflammation. Often, the inflammation is sub-clinical and patients will not be aware of the vascularization, nor will they have any visual complaints. Contact lens wear and eyelid inflammation (blepharitis) are classically associated with asymptomatic pannus formation. More obvious causes of inflammation and corneal neovascularization include corneal ulcers, traumatic corneal scars, and atopic keratoconjunctivitis. Though the blood vessels are nonspecific, they do indicate a chronicity of inflammation as blood vessels do not migrate into the cornea acutely.

Try VisualDx FREE for 30 days

VisualDx is your key to a faster, more accurate diagnosis.

Sign up today and receive a FREE 30-day trial to the VisualDx Essentials Package.

Your VisualDx subscription includes mobile access via our Apple and Android apps.

VisualDx is a web-based clinical decision support system used in over 1,500 hospitals and large clinics. Learn more.

Get your FREE 30-day trial